Baker Brothers Advisors - ENDOCYTE INC ownership

ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 97 filers reported holding ENDOCYTE INC in Q2 2016. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of ENDOCYTE INC
ValueSharesWeighting
Q3 2018$45,254,000
+44.0%
2,548,069
+11.9%
0.30%
+26.3%
Q2 2018$31,434,000
+51.8%
2,277,7990.0%0.24%
+34.9%
Q1 2018$20,705,000
+344.9%
2,277,799
+109.5%
0.18%
+337.5%
Q4 2017$4,654,000
+73.3%
1,087,323
+25.1%
0.04%
+66.7%
Q3 2016$2,685,000
-26.0%
868,983
-23.1%
0.02%
-36.8%
Q2 2016$3,629,000
-31.0%
1,130,577
-33.3%
0.04%
-30.9%
Q1 2016$5,257,000
-22.7%
1,695,8650.0%0.06%
-1.8%
Q4 2015$6,800,000
+9.4%
1,695,865
+25.0%
0.06%
-1.8%
Q3 2015$6,213,0001,356,5520.06%
Other shareholders
ENDOCYTE INC shareholders Q2 2016
NameSharesValueWeighting ↓
Corbenic Partners LLC 32,639$83,0000.09%
Anson Funds Management LP 108,426$276,0000.09%
Leisure Capital Management 30,038$77,0000.07%
HIGHLAND CAPITAL MANAGEMENT LP 461,561$1,177,0000.06%
Teza Capital Management LLC 14,542$37,0000.05%
PINNACLE ASSOCIATES LTD 821,543$2,095,0000.04%
Cribstone Capital Management, LLC 28,141$63,0000.04%
RMB Capital Management, LLC 243,385$621,0000.03%
Acrospire Investment Management LLC 26,061$66,0000.03%
TWO SIGMA SECURITIES, LLC 26,758$68,0000.02%
View complete list of ENDOCYTE INC shareholders